<code id='6D82F39BF6'></code><style id='6D82F39BF6'></style>
    • <acronym id='6D82F39BF6'></acronym>
      <center id='6D82F39BF6'><center id='6D82F39BF6'><tfoot id='6D82F39BF6'></tfoot></center><abbr id='6D82F39BF6'><dir id='6D82F39BF6'><tfoot id='6D82F39BF6'></tfoot><noframes id='6D82F39BF6'>

    • <optgroup id='6D82F39BF6'><strike id='6D82F39BF6'><sup id='6D82F39BF6'></sup></strike><code id='6D82F39BF6'></code></optgroup>
        1. <b id='6D82F39BF6'><label id='6D82F39BF6'><select id='6D82F39BF6'><dt id='6D82F39BF6'><span id='6D82F39BF6'></span></dt></select></label></b><u id='6D82F39BF6'></u>
          <i id='6D82F39BF6'><strike id='6D82F39BF6'><tt id='6D82F39BF6'><pre id='6D82F39BF6'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:396
          Person wearing a blue glove holding money against a blue backdrop.
          Adobe

          WASHINGTON — Medicare officials are moving forward with a plan to claw back money from certain hospitals to try to remedy overpayments struck down by the Supreme Court, they announced Thursday.

          A federal court ordered the Department of Health and Human Services to compensate hospitals that receive discounted drugs through the 340B program for billions of dollars of underpayments, but the money had already gone out to hospitals that didn’t participate in the program.

          advertisement

          Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in the drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          An innovative path out of biotech’s “valley of death”
          An innovative path out of biotech’s “valley of death”

          AdobeSomanypromisingmedicalinnovationsneverreachtheirfullpotentialastherapiesorcures,languishinginst

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          ASCO Takeaways: Winners, snoozers, and the art of cancer care

          ThousandsofoncologistsbadeChicagoagoodnight.ADAMFEUERSTEIN/STATYou’rereadingthewebeditionofASCOin30S